Contrast-enhanced mammography in the management of breast architectural distortions and avoidance of unnecessary biopsies
Breast Cancer · 2024
DOI: 10.1007/s12282-024-01599-x ↗Kurz gefasst
Fachartikel in der Zeitschrift Breast Cancer, 2024. Verfasst von Chiara Bellini und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiology, Breast Imaging Unit, Azienda Ospedaliero-Universitaria Careggi, Florence, Italy. 1chiarabellini@gmail.com. Hauptthemen laut MEDLINE: Mammography, Breast Neoplasms, Contrast Media. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 40 Literaturangaben.
Abstract (Originalsprache)
BACKGROUND: To assess contrast-enhanced mammography (CEM) in the management of BI-RADS3 breast architectural distortions (AD) in digital breast tomosynthesis (DBT). METHODS: We retrospectively reviewed 328 women with 332 ADs detected on DBT between 2017 and 2021 and selected those classified as BI-RADS3 receiving CEM as problem-solving. In CEM recombined images, we evaluated AD's contrast enhancement (CE) according to its presence/absence, type, and size. AD with enhancement underwent imaging-guided biopsy while AD without enhancement follow-up or biopsy if detected in high/intermediate-risk women. RESULTS: AD with enhancement were 174 (52.4%): 72 (41.4%) were malignant lesions, 102 (59.6%) false positive results: 28 (16%) B3 lesions, and 74 (42.5%) benign lesions. AD without enhancement were 158 (47.6%): 26 (16.5%) were subjected to biopsy (1 malignant and 25 benign) while the other 132 cases were sent to imaging follow-up, still negative after two years. CEM's sensitivity, specificity, positive (PPV) and negative predictive values (NPV), and accuracy were 98.63%, 60.62%, 41.38%, 99.37%, and 68.98%. The AUC determined by ROC was 0.796 (95% CI, 0.749-0.844). CONCLUSION: CEM has high sensitivity and NPV in evaluating BI-RADS3 AD and can be a complementary tool in assessing AD, avoiding unnecessary biopsies without compromising cancer detection.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Radiology, Breast Imaging Unit, Azienda Ospedaliero-Universitaria Careggi, Florence, Italy. 1chiarabellini@gmail.com.
- Department of Radiology, Breast Imaging Unit, Azienda Ospedaliero-Universitaria Careggi, Florence, Italy.
- Department of Radiology, Breast Imaging Unit, "Ospedale San Giovanni di Dio", Agrigento, Italy.
- Breast Surgery Unit, Azienda Ospedaliero-Universitaria Careggi, Florence, Italy.
- Department of Radiology, Azienda Ospedaliero-Universitaria Careggi, Florence, Italy.
Zitieren
APA
Bellini, C., Pugliese, F., Bicchierai, G., Amato, F., De Benedetto, D., Di Naro, F., Boeri, C., Vanzi, E., Migliaro, G., Incardona, L., Tommasi, C., Orzalesi, L., Miele, V., & Nori, J. (2024). Contrast-enhanced mammography in the management of breast architectural distortions and avoidance of unnecessary biopsies. Breast Cancer. https://doi.org/10.1007/s12282-024-01599-x
Vancouver
Bellini C, Pugliese F, Bicchierai G, Amato F, De Benedetto D, Di Naro F, et al. Contrast-enhanced mammography in the management of breast architectural distortions and avoidance of unnecessary biopsies. Breast Cancer. 2024. doi:10.1007/s12282-024-01599-x
BibTeX
@article{Bellini2024,
author = {Bellini, Chiara and Pugliese, Francesca and Bicchierai, Giulia and Amato, Francesco and De Benedetto, Diego and Di Naro, Federica and Boeri, Cecilia and Vanzi, Ermanno and Migliaro, Giuliano and Incardona, Ludovica and Tommasi, Cinzia and Orzalesi, Lorenzo and Miele, Vittorio and Nori, Jacopo},
title = {Contrast-enhanced mammography in the management of breast architectural distortions and avoidance of unnecessary biopsies},
journal = {Breast Cancer},
year = {2024},
doi = {10.1007/s12282-024-01599-x}
}
EUVIMED